Jacqueline Barry

Chief Clinical Officer • CGT Catapult

Jacqueline joined Cell and Gene Therapy Catapult as Director of Regulatory Affairs and has since been promoted to Chief Clinical Officer. Prior to this, Jacqueline worked at the Scottish National Blood Transfusion Service in several senior regulatory and quality positions, the responsibility for which included designing the regulatory strategy for the Cellular Therapies developed by the Blood Transfusion Service acting as Responsible Person for Blood and Qualified Person for medicinal product release. Before that, she held a number of post-Doctoral academic posts at the University of Edinburgh, studying neuromuscular regeneration. She has considerable experience in the development, translation, clinical trial and approval of cell-based medicinal products and therapies. 


Also speaking

Eric Strati

Chief Executive Officer • Gift of Life Biologics

Elisabet Aguilar

Expert in Quality and Improvement of Advanced Therapies • Andalusian Network for Design and Translation of Advanced Therapies

Lynn Fischer

Chief Executive Officer • TITLE21 Health Solutions

Event Info


Sponsorship Opportunities Waiting List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.


Find out more about partnering at Advanced Therapies Europe.